Paladin to buy troubled Labopharm for $20M; Abbott gets FDA approval for Lupron doses;

@FiercePharma: Crain's NY predicts Forest Labs will prevail in today's shareholder vote, but Icahn isn't known for giving up easily. Story | Follow @FiercePharma

> Paladin has agreed to buy Labopharm, a Canadian company specializing in controlled release drugs, for about $20.4 million in an effort to strengthen its pain franchise. News | Report

> Abbott Laboratories got the FDA nod for two longer-acting doses of its drug Lupron for use in treating premature puberty. Story

> The Generic Pharmaceutical Association spent about $508,000 on lobbying during the second quarter, focusing primarily on patent issues and healthcare reform provisions covering biosimilar drugs. Item

> Continuing its share-buyback program, AstraZeneca purchased 750,000-plus shares at a price of 2845 pence per share. Article

> Shortages of some hospital drugs have grown so extreme that gray-market scalpers are hawking supplies at exorbitant prices. Story

> Moody's Investors Service hiked its outlook on Biogen Idec to "positive" from "stable" and affirmed its Baa3 rating on $1.1 billion in debt. News

> Hospira shares rose after a Citi Investment Research analyst upgraded them to "hold" from "sell." Piece

Biotech News

@FierceBiotech: Zogenix plots marketing app as pain drug clears PhIII. More | Follow @FierceBiotech

@JohnCFierce: WSJ article on online "dating service" approach to matching approved drugs to new uses. Piece | Follow @JohnCFierce

@RyanMFierce: Far out. Boston Herald reports budding prospects of a Mass. biotech that has sequenced the cannabis genome. Item | Follow @RyanMFierce

@MaureenFierce: Only half of doctors surveyed were aware Brilinta was approved. Most won't switch patients from Plavix. #sermosurveys. Report | Follow @MaureenFierce

> Amarin shares slide as investors fret over fate of AMR101 patent. More

> Stanford investigators match old drugs with new medical uses. Story

> Gentium tanks after it yanks drug apps on FDA data concerns. Report

Manufacturing News

> Turkeys drive Congress to antibiotic action. News

> FDA aims for quality through regulatory science. Story

> The other dark side of Merck's 13,000 layoffs. More

> Recalls expert: Keep a close eye on regulators. Article

> New cause found in most recent Tylenol recall. Details

Vaccine News

> Carbohydrate key to C. diff vaccine. Details

> Novel antibodies could lead to AIDS vaccine. More

> USAID, IDRI form malaria vax collaboration. Report

> TapImmune, Mayo Clinic announce PhI breast cancer vaccine trial. News

> Inviragen, U of Texas land $3M grant for chikungunya vaccine. Article

And Finally... Smokers have a higher risk of bladder cancer than previously believed, perhaps because of new chemicals in cigarettes. Report